Cargando…

Therapy optimization in patients with heart failure: the role of the wearable cardioverter-defibrillator in a real-world setting

BACKGROUND: The wearable cardioverter-defibrillator (WCD) has emerged as a valuable tool to temporarily protect patients at risk for sudden cardiac death (SCD). The aim of this study was to determine the value of the WCD for therapy optimization of heart failure patients. METHODS: One hundred five c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Röger, Susanne, Rosenkaimer, Stefanie L., Hohneck, Anna, Lang, Siegfried, El-Battrawy, Ibrahim, Rudic, Boris, Tülümen, Erol, Stach, Ksenija, Kuschyk, Jürgen, Akin, Ibrahim, Borggrefe, Martin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5856002/ https://www.ncbi.nlm.nih.gov/pubmed/29544442 http://dx.doi.org/10.1186/s12872-018-0790-8

Ejemplares similares

The Wearable Cardioverter-Defibrillator: Experience in 153 Patients and a Long-Term Follow-Up
por: Rosenkaimer, Stephanie L., et al.
Publicado: (2020)

Low Prevalence of Inappropriate Shocks in Patients With Inherited Arrhythmia Syndromes With the Subcutaneous Implantable Defibrillator Single Center Experience and Long‐Term Follow‐Up
por: Rudic, Boris, et al.
Publicado: (2017)

Real life experience with the wearable cardioverter-defibrillator in an international multicenter Registry
por: El-Battrawy, Ibrahim, et al.
Publicado: (2022)

Long‐term results of combined cardiac contractility modulation and subcutaneous defibrillator therapy in patients with heart failure and reduced ejection fraction
por: Röger, Susanne, et al.
Publicado: (2018)

Local dose rate effects in implantable cardioverter–defibrillators with flattening filter free and flattened photon radiation
por: Gauter-Fleckenstein, Benjamin, et al.
Publicado: (2022)

Implantable cardioverter‐defibrillator in Brugada syndrome: Long‐term follow‐up
por: El‐Battrawy, Ibrahim, et al.
Publicado: (2019)

Long‐Term Follow‐Up of Patients With Short QT Syndrome: Clinical Profile and Outcome
por: El‐Battrawy, Ibrahim, et al.
Publicado: (2018)

Incremental benefit of late gadolinium cardiac magnetic resonance imaging for risk stratification in patients with hypertrophic cardiomyopathy
por: Doesch, Christina, et al.
Publicado: (2017)

Prediction of cardiac events with non‐contrast magnetic resonance feature tracking in patients with ischaemic cardiomyopathy
por: Overhoff, Daniel, et al.
Publicado: (2021)

Septal myocardial scar burden predicts the response to cardiac contractility modulation in patients with heart failure
por: Ansari, Uzair, et al.
Publicado: (2022)

Simultaneous Non‐Invasive Epicardial and Endocardial Mapping in Patients With Brugada Syndrome: New Insights Into Arrhythmia Mechanisms
por: Rudic, Boris, et al.
Publicado: (2016)

Impact of Sacubitril/Valsartan on the Long-Term Incidence of Ventricular Arrhythmias in Chronic Heart Failure Patients
por: El-Battrawy, Ibrahim, et al.
Publicado: (2019)

Use of the Wearable Cardioverter‐Defibrillator Among Patients With Myocarditis and Reduced Ejection Fraction or Ventricular Tachyarrhythmia: Data From a Multicenter Registry
por: El‐Battrawy, Ibrahim, et al.
Publicado: (2023)

Blood Cholesterol and Outcome of Patients with Cancer under Regular Cardiological Surveillance
por: Hohneck, Anna Lena, et al.
Publicado: (2021)

Incidence and Prognostic Relevance of Cardiopulmonary Failure in Takotsubo Cardiomyopathy
por: El-Battrawy, Ibrahim, et al.
Publicado: (2017)

Combined implantation of dual-chamber ICD and optimizer through a persistent left superior vena cava
por: Fastenrath, Fabian, et al.
Publicado: (2016)

Hyperthermia Influences the Effects of Sodium Channel Blocking Drugs in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes
por: El-Battrawy, Ibrahim, et al.
Publicado: (2016)

First experience with the wearable cardioverter defibrillator in the Netherlands
por: Knops, R. E., et al.
Publicado: (2011)

Wearable cardioverter defibrillator: Bridge or alternative to implantation?
por: Barraud, Jeremie, et al.
Publicado: (2017)

Multiparameter Monitoring with a Wearable Cardioverter Defibrillator
por: Rohrer, Ursula, et al.
Publicado: (2021)

Usage of the wearable cardioverter-defibrillator during pregnancy
por: Olic, J.-Jacqueline, et al.
Publicado: (2022)

Clinical outcomes associated with catecholamine use in patients diagnosed with Takotsubo cardiomyopathy
por: Ansari, Uzair, et al.
Publicado: (2018)

An appropriate shock of the wearable cardioverter-defibrillator in an outpatient setting
por: Kishihara, Jun, et al.
Publicado: (2016)

Bridge to avoid ICD implantation with wearable cardioverter defibrillators
por: Zoppo, Franco, et al.
Publicado: (2020)

A Tragic Case of Wearable Cardioverter-Defibrillator Failure
por: Vinas, Ariel, et al.
Publicado: (2021)

Phantom Shocks Associated With a Wearable Cardioverter Defibrillator
por: Delle Donna, Paul, et al.
Publicado: (2021)

Experience with a Wearable Cardioverter-defibrillator in 436 Patients
por: Nägele, Herbert, et al.
Publicado: (2022)

Wearable cardioverter‐defibrillator: friend or foe in suspected myocarditis?
por: Blaschke, Florian, et al.
Publicado: (2021)

Capsule Endoscopy in a Patient with an Implanted CCM System and an Implantable Defibrillator
por: Streitner, Florian, et al.
Publicado: (2011)

Clinical Outcomes in Patients with Ischemic versus Non-Ischemic Cardiomyopathy after Angiotensin-Neprilysin Inhibition Therapy
por: Abumayyaleh, Mohammad, et al.
Publicado: (2021)

Sudden Cardiac Arrest in Hemodialysis Patients with Wearable Cardioverter Defibrillator
por: Wan, Chingping, et al.
Publicado: (2013)

Oversensing of the wearable cardioverter defibrillator during bipolar ventricular stimulation
por: Manninger, Martin, et al.
Publicado: (2017)

Wearable Cardioverter Defibrillator　― Initial Experience in the Outpatient Setting in Japan ―
por: Horiguchi, Ai, et al.
Publicado: (2020)

The wearable cardioverter-defibrillator is not needed for most high-risk patients
por: Bhatt, Advay G., et al.
Publicado: (2020)

The wearable cardioverter-defibrillator is needed for most high-risk patients
por: Lee, Byron K.
Publicado: (2020)

Update on Wearable Cardioverter Defibrillator: A Comprehensive Review of Literature
por: Alsamman, Mrhaf, et al.
Publicado: (2022)

Prevalence, Clinical Characteristics, and Predictors of Patients with Thromboembolic Events in Takotsubo Cardiomyopathy
por: El-Battrawy, Ibrahim, et al.
Publicado: (2016)

Avoiding Untimely Implantable Cardioverter/Defibrillator Implantation by Intensified Heart Failure Therapy Optimization Supported by the Wearable Cardioverter/Defibrillator—The PROLONG Study
por: Duncker, David, et al.
Publicado: (2017)

The impact of wearable cardioverter-defibrillator use on long-term decision for implantation of a cardioverter-defibrillator in a semirural acute care hospital
por: Sinha, Anil-Martin, et al.
Publicado: (2020)

A wearable cardioverter defibrillator with a low false alarm rate
por: Poole, Jeanne E., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_pnfrru818bk6g3ua3c0jelssa6